Henry Schein, Inc. (HSIC) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Henry Schein, Inc. (HSIC) Healthcare & Pipeline Overview

Henry Schein, Inc. is a leading global distributor of healthcare products and services, focusing on dental and medical professionals. With a broad portfolio encompassing consumables, equipment, and technology solutions, the company supports healthcare providers in optimizing practice efficiency and patient care, operating with a consistent profit margin.

What Is the Investment Thesis for HSIC?

With a market capitalization of $10.0B and a P/E ratio of 25.23, the company showcases stability and growth potential. The company's gross margin of 29.7% and profit margin of 3.0% reflect efficient operations. Key growth catalysts include the expansion of its technology and value-added services segment and strategic acquisitions to broaden its product portfolio. However, potential risks include increasing competition in the healthcare distribution market and regulatory changes impacting healthcare practices. The company's beta of 0.88 suggests lower volatility compared to the broader market.

Based on FMP financials and quantitative analysis

HSIC Key Highlights

Market capitalization of $10.0B indicates a strong market presence.

• P/E ratio of 25.23 reflects investor confidence in future earnings.
• Gross margin of 29.7% demonstrates efficient cost management.
• Profit margin of 3.0% shows consistent profitability.
• Beta of 0.88 suggests lower volatility compared to the broader market.

Who Are HSIC's Competitors?

HSIC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are HSIC's Key Strengths?

Global distribution network.

• Comprehensive product portfolio.
• Strong brand reputation.
• Value-added services.

What Are HSIC's Weaknesses?

Dependence on third-party suppliers.

• Exposure to regulatory changes.
• Limited pricing power.
• Relatively low profit margin.

What Could Drive HSIC Stock Higher?

Expansion of digital commerce platform to enhance customer experience and drive online sales.

• Strategic acquisitions to broaden product portfolio and expand geographic reach.
• Growth in technology and value-added services segment.
• Increasing demand for healthcare products and services in emerging markets.

What Are the Key Risks for HSIC?

Increasing competition in the healthcare distribution market.

• Regulatory changes impacting healthcare practices and reimbursement rates.
• Supply chain disruptions affecting product availability and costs.
• Economic downturns reducing healthcare spending.

What Are the Growth Opportunities for HSIC?

• Expansion of Technology and Value-Added Services: Henry Schein can drive growth by expanding its technology and value-added services segment. The market for practice management software and e-services is growing as healthcare providers seek to improve efficiency and patient care. By offering innovative solutions and expanding its service offerings, Henry Schein can attract new customers and increase revenue. This segment addresses a market estimated to reach $10 billion by 2028.
• Strategic Acquisitions: Henry Schein can pursue strategic acquisitions to broaden its product portfolio and expand its geographic reach. By acquiring companies with complementary products or services, Henry Schein can enhance its market position and increase its revenue base. The company has a history of successful acquisitions and can leverage its expertise to identify and integrate new businesses. The timeline for acquisitions is ongoing, with potential deals assessed annually.
• Penetration of Emerging Markets: Henry Schein can expand its presence in emerging markets, where demand for healthcare products and services is growing rapidly. By establishing distribution networks and partnerships in these markets, Henry Schein can tap into new revenue streams and diversify its geographic footprint. Emerging markets represent a significant growth opportunity, with healthcare spending projected to increase by 8-10% annually over the next decade.
• Enhancement of Digital Commerce Platform: Investing in and enhancing its digital commerce platform can significantly boost Henry Schein's growth. A user-friendly and efficient online platform can attract more customers, streamline ordering processes, and improve customer satisfaction. This initiative aligns with the broader trend of digitalization in the healthcare industry. The timeline for platform enhancements is projected over the next 2-3 years.
• Focus on Value-Based Care Solutions: As the healthcare industry shifts towards value-based care models, Henry Schein can develop and offer solutions that support these models. This includes providing data analytics, consulting services, and technology solutions that help healthcare providers improve patient outcomes and reduce costs. The market for value-based care solutions is expected to grow significantly, presenting a substantial opportunity for Henry Schein. Implementation of these solutions is expected to ramp up over the next 5 years.

What Are HSIC's Competitive Advantages?

• Extensive distribution network provides a wide reach to customers.
• Strong relationships with manufacturers and suppliers ensure product availability.
• Comprehensive portfolio of products and services caters to diverse customer needs.
• Established brand reputation and customer loyalty.
• Value-added services enhance customer stickiness.

What Does HSIC Do?

Founded in 1932 and headquartered in Melville, New York, Henry Schein, Inc. has evolved into a global leader in distributing healthcare products and services. The company began as a pharmacy and has expanded its offerings to serve dental practitioners and laboratories, physician practices, government, institutional healthcare clinics, and other alternate care clinics worldwide. Henry Schein operates through two primary segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment provides a comprehensive range of dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, and digital restoration equipment. It also offers medical products such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, and infection-control products. The Technology and Value-Added Services segment delivers software, technology, and other value-added services, including practice management software systems, financial services, e-services, practice technology, network, and hardware services, as well as continuing education and consulting services. With a global presence and a commitment to innovation, Henry Schein supports healthcare professionals in delivering quality patient care and improving practice efficiency.

What Products and Services Does HSIC Offer?

• Distributes dental products, including infection-control supplies and equipment.
• Provides medical products, such as pharmaceuticals, vaccines, and surgical supplies.
• Offers practice management software systems for dental and medical practitioners.
• Delivers value-added practice solutions, including financial services and e-services.
• Provides continuing education services for healthcare professionals.
• Offers equipment repair services for dental and medical equipment.
• Supplies personal protective equipment (PPE) to healthcare providers.

How Does HSIC Make Money?

• Distribution of healthcare products to dental and medical professionals.
• Sale of technology and value-added services, including software and consulting.
• Revenue generated through product sales and service fees.
• Strategic partnerships with manufacturers and suppliers.

What Industry Does HSIC Operate In?

Henry Schein, Inc. operates within the medical distribution industry, which is characterized by increasing demand for healthcare products and services due to an aging population and advancements in medical technology. The industry is competitive, with companies like Globus Medical, Inc. (GMED) and Masimo Corporation (MASI) vying for market share. Trends include the growing adoption of digital solutions and the increasing importance of value-added services. Henry Schein's focus on both distribution and technology positions it favorably to capitalize on these trends.

Who Are HSIC's Key Customers?

• Dental practitioners and laboratories.
• Physician practices.
• Government and institutional healthcare clinics.
• Alternate care clinics.

Henry Schein, Inc. (HSIC) Valuation Context

Valued at $10.0B, HSIC is classified as a large-cap stock. Analyst price targets span from $64.00 to $110.00, with a consensus of $92.33. At the current price of $87.90, that implies approximately 5% upside potential. Relative to its peer group, HSIC's quantitative score of 70/100 is roughly in line with the peer average of 65/100.

HSIC Revenue & Earnings Trend

In Q2 FY2026, HSIC generated $3.46B in top-line revenue, marking a sequential increase of 2.7%. The company recorded net income of $94.0M, with diluted EPS of $0.82. Quarter-over-quarter revenue has been mixed, typical for a large-cap company operating in Healthcare. Across the four most recent quarters, HSIC averaged $0.86 in diluted EPS.

Company Profile

Henry Schein, Inc. operates in the Medical - Distribution industry within the Healthcare sector. It is headquartered in Melville, US. The company is led by CEO Frederick Lowery. HSIC has traded publicly since 1995.

Return on equity for Henry Schein, Inc. stands at 11.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 3.5%, showing how much profit it generates from its asset base. HSIC trades at a trailing price-to-earnings ratio of 25.23, above the Healthcare sector average of ~21.50x. Its free cash flow yield is 4.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.36 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 4.1%, the inverse of the P/E and a quick read on earnings relative to price.

Henry Schein, Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.82 places it in the grey zone, a middle ground that warrants monitoring.

Henry Schein, Inc. has beaten Wall Street's EPS estimate in 6 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 2.9% above estimates on average.

Over the past six months, Henry Schein, Inc. insiders filed 16 SEC Form 4 transactions — 14 sales and 2 purchases. On net that is roughly 11K shares disposed (about $739K), a signal worth weighing alongside the fundamentals.

HSIC Financials

HSIC earnings history & estimates →

HSIC Latest News

HSIC Analyst Consensus

HSIC MoonshotScore

Latest Henry Schein, Inc. Analysis

What Investors Ask About Henry Schein, Inc. (HSIC) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources